MediLens Intelligence
Features

醫學研究趨勢

AI精選本週最具影響力的29個專科論文

最後更新: 2026年5月22日

消化內科5

影響力 2

Amplification of pro-proliferative genes adjacent to the F3 gene in pancreatic adenocarcinoma is associated with worse outcomes.

發表日期: 2026-12-01

Cell cycle (Georgetown, Tex.)

MediLens 收錄日: 2026-05-23

This study explores the relationship between gene amplification of ARHGAP29 and SLC44A3 and the elevated expression of the F3 gene in pancreatic adenocarcinoma (PAAD). Using CNV analyses from CPTAC-PAAD and TCGA-PAAD data sets, it was found that patients with higher CNs for these genes had signif...

在PubMed上閱讀
影響力 2

發表日期: 2026-12-01

Journal of enzyme inhibition and medicinal chemistry

MediLens 收錄日: 2026-05-22

This study investigates the p53-Y220C mutation, which is associated with increased aggressivity in gastric cancer and offers a target for small molecule therapies. The mutation causes misfolding of p53 due to thermal instability and creates a pocket for small molecules, along with an additional f...

在PubMed上閱讀
影響力 3

Reprogramming of the hepatic ubiquitin‑immune axis: A unifying mechanism in liver disease progression (Review).

發表日期: 2026-07-01

Molecular medicine reports

MediLens 收錄日: 2026-05-23

This review proposes a new paradigm for the progression of liver disease, suggesting it arises from systematic reprogramming of the ubiquitin code in the hepatic microenvironment. Key E3 ligases and deubiquitinases shift from protective roles to drivers of disease progression, affecting various c...

在PubMed上閱讀
影響力 3

ZBTB16 upregulation maintains copper homeostasis to support esophageal tumor progression.

發表日期: 2026-07-01

Molecular medicine reports

MediLens 收錄日: 2026-05-23

This study investigates the role of ZBTB16 in esophageal cancer, revealing that it is highly expressed in cancer tissues and cell lines. Knockdown of ZBTB16 inhibited cancer cell proliferation and migration, increased cell death, and affected mitochondrial function. In vivo, ZBTB16 knockdown supp...

在PubMed上閱讀
影響力 2

Integrin beta 4 promotes colorectal cancer progression by upregulating Ezrin and activating the Wnt/β‑catenin signaling pathway.

發表日期: 2026-07-01

International journal of oncology

MediLens 收錄日: 2026-05-23

The study investigates the role of Integrin beta 4 (ITGB4) in colorectal cancer (CRC) progression, aiming to clarify its oncogenic mechanism and identify downstream molecular effectors for potential targeted therapy.

在PubMed上閱讀

獲取個人化每日摘要

全球醫生每天早上以AI文獻綜述開始新的一天。每早七點透過郵件發送。

開始7天免費試用